Elderly breast cancer patients denied life-saving drugs, says new study

by Maggie Clune

(Medical Xpress)—Just 14 per cent of patients aged over 70 with early breast cancer are offered standard chemotherapy after surgery, says a new study by researchers from the University of Sussex and Brighton and Sussex Medical School.

The study, led by Professor Lesley Fallowfield, Director of Sussex Health Outcomes Research & Education in Cancer, University of Sussex, found that many elderly patients (an average age of 78.5yrs) who had previously had surgery to remove a breast tumour were not being offered adjuvant (ie, additional treatment) – the standard of care in younger patients.

The study "Adjuvant Chemotherapy in Elderly Women with ," also highlighted that in nearly a third (29 per cent) of the 803 case studies examined, clinicians made a decision on what treatment to give a patient without recording their fitness or understanding their HER2 status.

HER2 is a receptor found on the surface of all cells. Like a satellite dish, it sends messages or 'signals' into the cell telling it to survive and multiply. In HER2-positive breast cancer, there are too

many HER2 receptors on the surface of cancerous cells. As a result, the cells receive a high number of 'survive and multiply' signals – causing rapid growth and spread of the tumour. Knowledge of a patient's type, stage and HER2 status therefore plays a part in deciding the most appropriate care for the patient.

There are many different types of breast cancer. Patients who test HER2 positive could be offered the personalised antibody treatment called Herceptin, together with chemotherapy, which significantly increases chances of survival for HER2-positive breast cancer patients compared to those offered chemotherapy alone.

Only 14 per cent of the study group, who were more likely to be younger patients (under 74 yrs), were offered chemotherapy. Further, of the 45 per cent of patients in the study who were considered at high risk of recurrence, less than a third were offered chemotherapy. If patients are not given chemotherapy then Herceptin will not be given either.

The likelihood of being offered chemotherapy also varied by hospital.

Professor Fallowfield says: "Elderly breast cancer patients should be assessed in the same way that younger patients are, based on their performance status and their HER2 status, without prejudice or unreasonably ageist perceptions. This is essential information, and without it, you may as well guess as to the most appropriate treatment.

"National guidelines need to be developed to support treatment recommendations if elderly patients are to receive fair and equal assessment of their treatment requirements in future.

"There may be legitimate reasons not to offer chemotherapy to older women with breast cancer: in some the benefits may be very small or the patient may not be fit enough for treatment.

"However, it is clear from this research that some clinicians are basing their decisions on perception rather than fact."

Dr Alistair Ring, a co-author of the paper and Senior Lecturer in Oncology at Brighton and Sussex , which is run jointly by the universities of Sussex and Brighton, adds:  "It is impossible to know what the benefits of a particular treatment regimen are compared to an alternative without knowing how fit the patient is and what type of breast cancer they have."

More information: annonc.oxfordjournals.org/cont… /01/17/annonc.mds642

add to favorites email to friend print save as pdf

Related Stories

Breast cancer recurrence defined by hormone receptor status

Oct 01, 2012

Human epidermal growth factor (HER2) positive breast cancers are often treated with the same therapy regardless of hormone receptor status. New research published in BioMed Central's open access journal Breast Cancer Research shows ...

Recommended for you

Pepper and halt: Spicy chemical may inhibit gut tumors

3 hours ago

Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining ...

Expressive writing may help breast cancer survivors

5 hours ago

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

Taking the guesswork out of cancer therapy

11 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

12 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

12 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

User comments